Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing rectus sheath block with liposomal bupivacaine versus thoracic epidural analgesia for pain control after pancreatoduodenectomy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal Bupivacaine (Exparel) (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Duodenal Neoplasm, Pancreatic Neoplasm | Phase 2 | Status: RECRUITING